NCT06405373
| Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART | No drug interventions | treatment | Not Available | recruiting |
NCT06405386
| Pilot of Pragmatic Delivery of Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes | No drug interventions | treatment | Not Available | active_not_recruiting |
NCT03406897
| Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients | | treatment | 1 / 2 | completed |
NCT03243058
| Low-dose IL-2 in Established T1D - The "PROREG" Study | | treatment | 1 / 2 | withdrawn |
NCT05168657
| Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth | No drug interventions | treatment | Not Available | completed |
NCT04074668
| Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance | | Not Available | Not Available | completed |
NCT03878277
| Evaluation of Coffee Therapy for Improvement of Renal Oxygenation | No drug interventions | treatment | 2 | completed |
NCT06573905
| Mapping Diabetes in Quebec: Validating Medico-administrative Algorithms for Type 1 Diabetes, Type 2 Diabetes and LADA | No drug interventions | Not Available | Not Available | not_yet_recruiting |
NCT01109927
| Early Insulin Treatment in Patients With Latent Autoimmune Diabetes | | treatment | 4 | completed |
NCT05013346
| Characteristics of Young-onset Diabetes in Sub-Saharan Africa (YODA) Study | No drug interventions | Not Available | Not Available | unknown_status |
NCT00058981
| Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA) | | treatment | 2 | terminated |
NCT00837759
| Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes | | treatment | 2 | terminated |
NCT04335513
| Trial of Early Initiation of CGM-Guided Insulin Therapy in Stage 2 T1D | No drug interventions | treatment | Not Available | unknown_status |
NCT04698330
| Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA | | treatment | 4 | not_yet_recruiting |
NCT02081326
| Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes | No drug interventions | treatment | 2 | active_not_recruiting |
NCT04793165
| Is the Artificial Pancreas, Without Carbohydrate Counting, Efficient and Safe in an Outpatient Setting | No drug interventions | device_feasibility | Not Available | completed |
NCT03513874
| Metformin Plus Insulin on Non-obese Autoimmune Diabetes | | treatment | 4 | unknown_status |
NCT03618420
| Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function | | diagnostic | 1 / 2 | completed |
NCT03345004
| Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes | | treatment | 2 | completed |
NCT03011008
| Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus | | treatment | 4 | unknown_status |
NCT01148238
| Autoimmune Diabetes: Markers of the Disease and Treatment of Latent Autoimmune Diabetes in Adults (LADA) | No drug interventions | Not Available | Not Available | withdrawn |
NCT05319990
| Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study) | | Not Available | Not Available | recruiting |
NCT03011021
| Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes | | treatment | 1 / 2 | recruiting |
NCT03945747
| MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus | No drug interventions | Not Available | Not Available | active_not_recruiting |
NCT04902807
| Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation | No drug interventions | Not Available | Not Available | not_yet_recruiting |
NCT01881009
| Medtronic Minimed Overnight Closed-Loop System | No drug interventions | treatment | Not Available | completed |
NCT05866536
| Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years | No drug interventions | treatment | 2 | recruiting |
NCT01559025
| Evaluation of Vildagliptin (GalvusĀ®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus | | treatment | 3 | unknown_status |
NCT05180591
| Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes | No drug interventions | treatment | 2 | recruiting |